Close Menu

NEW YORK (GenomeWeb) – The Alliance Global Group (AGBL) today announced an exclusive master distribution agreement for Fluxion Biosciences' IsoFlux and BioFlux systems in emerging markets in the Middle East, Asia, and Africa.

The IsoFlux Cell Separation System allows researchers to detect variants in circulating tumor cells by next-generation sequencing. The BioFlux System is for the introduction of flow conditions into research and drug discovery experiments to emulate the in vivo environment.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.